ViiV Healthcare Company drugs

14 results

  • apretude

    (Cabotegravir)
    ViiV Healthcare Company
    APRETUDE is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk of HIV-1. A negative HIV-1 test is required before starting treatment.
    Medication Details
    Drug Interactions

  • cabenuva

    (cabotegravir and rilpivirine)
    ViiV Healthcare Company
    CABENUVA is indicated for the treatment of HIV-1 in adults and adolescents (12 years and older, 35 kg+) as a complete regimen to replace current antiretroviral therapy in those who are virologically suppressed, with no history of treatment failure or known resistance to its components.
    Medication Details

  • dovato

    (dolutegravir sodium and lamivudine)
    ViiV Healthcare Company
    DOVATO is indicated for the treatment of HIV-1 infection in adults and adolescents (aged 12 and older, weighing at least 25 kg) either as a complete regimen for those with no prior treatment history or to replace the current regimen in virologically suppressed patients without resistance concerns.
    Medication Details
    Drug Interactions

  • juluca

    (dolutegravir sodium and rilpivirine hydrochloride)
    ViiV Healthcare Company
    JULUCA is indicated for treating HIV-1 infection in virologically suppressed adults, replacing their current antiretroviral regimen. Eligible patients must have maintained suppression for at least 6 months, have no treatment failures, and no known resistance to JULUCA's components.
    Medication Details
    Drug Interactions

  • rukobia

    (fostemsavir tromethamine)
    ViiV Healthcare Company
    RUKOBIA is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1, specifically for those failing their current antiretroviral regimen due to resistance, intolerance, or safety concerns, when used in combination with other antiretroviral medications.
    Medication Details
    Drug Interactions